Guardant Health CCO Chris Freeman Reports Routine RSU Vesting and Tax Withholding

Overview of the Filing

On October 2, 2026, Guardant Health, Inc. (NASDAQ: GH) filed a Form 4 on behalf of Chief Commercial Officer Chris Freeman detailing equity award activity executed on October 1, 2026.

Transaction Details

• RSU Conversions (Code M): The reporting person acquired a total of 7,416 shares of Common Stock across four vesting restricted stock unit (RSU) tranches:
  • 1,929 shares (from grant dated November 7, 2022)
  • 1,668 shares (from grant dated December 13, 2023)
  • 2,527 shares (from grant dated November 8, 2024)
  • 1,292 shares (from grant dated March 12, 2025)
• Tax Withholding (Code F): A total of 3,143 shares were retained by the issuer at a price of $174.75 per share (aggregate value of $549,239.25) to cover statutory tax withholding liabilities triggered by the vestings.
• Net Impact: The insider added a net 4,273 common shares to direct holdings, bringing direct beneficial ownership to 69,647 shares.

Market & Trading Significance

This filing reflects routine, scheduled equity compensation vesting rather than discretionary market trading. Because the disposition of 3,143 shares was conducted strictly for tax withholding obligations (Code F) and not an open-market sale (Code S), the trading significance is rated as Low and does not signal insider sentiment on company valuation.